eagledon pharmaceutical-最新凯时注册

mr zhang, the founder of the eagle group, was appointed to the board on 9 december 2016 as an executive director. he is primarily responsible for the group’s strategic development. from 1980 to 1985, he was the technical expert at the agricultural bureau of cangnan county (wenzhou). subsequently, he founded shenli ginseng co.,ltd to manufacture and sell ginseng health products. from 1995 to 2000, mr zhang became the chairman of changbaishan city ginseng co.,ltd. he has more than 30 years of experience in the health food and nutritional supplements industry.

mr zhang is also well connected socially and politically:

since 2007 consecutively served as a member of the national committee of chinese political party consultative conference in tong’an district;

acted as the vice chairman of the tong’an chamber of commerce;

acted as the standing deputy chairman of the xiamen health food and cosmetics association;

acted as the standing vice chairman of industry and commerce association, tong’an district, xiamen;

acted as the chairman of tong’an chamber of food business;

acted as the standing chair of the world chinese entrepreneur association.

acted as the standing deputy chairman of wenzhou commerce association in fujian province.

mr zhang was awarded an emba degree from xiamen university and kellogg business college, northwest university, usa.

mr smith was appointed to the board in december 2016 as a non executive director. on 18 november 2019, mr smith was appointed chairman.

andrew’s business career has focussed on finance and the financial markets in the asia pacific. utilising the experience gained in his working career, he now holds a number of non-executive and consulting positions.

in addition to this position, andrew is a non-executive director of gyrostat capital management pty ltd, a funds management company; chairman of aobo environmental technology ltd, a private company involved in industrial air treatment and residential battery technology, and responsible manager of dennis afsl pty ltd.

he was formerly the managing director and chief executive of the stockbroking and corporate finance group intersuisse ltd (now phillip capital) between 2000 to 2010.

prior to that andrew was chairman of the sedgwick group in the asia pacific between 1995 to 2000. andrew has also served on the boards of elk orthobiologics ltd, xpd soccer gear group ltd, zheng he global capital ltd and on the board of advice of aon risk services.

andrew holds a bachelor of economics and politics from monash university.

mr xu has over 25 years’ senior management experience, including roles with australian public and asx listed companies serving in the capacities of managing director, non-executive director, finance and marketing manager.
mr xu was a founder of itm corporation ltd, the core business which formed the foundation for aumake international limited (asx: au8) of which he was a non-executive director. he is now managing director for weyou corporation ltd and dynasty resources ltd (asx: dma). he was also a director of rma energy limited (asx: rmt), dragon energy limited (now named lotus resources limited asx: lot), uraniumsa limited (now named twenty seven co., ltd (asx: tsc), ktl technologies limited ，sino gold limited and lg household chemicals beijing co. ltd.
mr xu completed his masters of business administration at boise state university in the us. he holds a master of science – engineering from china national nuclear corporation and bachelor of science from nanjing university in china.
mr xu is a member of ausimm .

dr de kauwe studied a bachelor of science in pharmacology and physiology and a bachelor of dental surgery from the university of western australia, with post graduate certifications in oral surgery and implantology. he also holds a post graduate diploma in applied finance, majoring in corporate finance.  dr de kauwe is an experienced operations and transaction focused executive with key skills in creating company value through strategic partnerships and mergers and acquisitions, with particular experience in the biotechnology, life sciences and technology sectors.

dr de kauwe is a director of a private investment banking firm with vast experience in corporate restructuring and recapitalisations, mergers and acquisitions, as well as public market transactions and equity capital markets in both australia and internationally. he has served as chairman and/or director of numerous asx listed companies.

mr vos is a member of theaustralian institute of company directors (aicd), the governance institute ofaustralia (gia), the chartered accountants in australia and new zealand (caanz)  and certified practising accountants of australia (cpa)  with more than 15 years’ experience working within public practice, specifically within the areaof corporate services and audit and assurance both in australia and south africa. he holds similar secretarial roles in various other listed publiccompanies in both industrial and resource sectors.  he is a director at nexia perth, a mid-tier corporate advisory and accounting practice.